Drug Trial Radar · NCT05059327
Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
61
Actual
Start
Mar 3, 2022
Primary completion
Feb 6, 2025
Study completion Apr 28, 2025
Sponsor
- Lead sponsor
- Noema Pharma AGIndustry
- Sponsor type
- Industry
- First posted
- Sep 28, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study intends to show that basimglurant (NOE-101) provides effective seizure control in children, adolescents and young adults with Tuberous Sclerosis Complex (TSC).
Conditions
- Tuberous Sclerosis Complex
Interventions
Basimglurant with crossover to PlaceboDrug
Basimglurant with crossover to Placebo
Placebo with crossover to BasimglurantDrug
Placebo with crossover to Basimglurant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean percentage in monthly seizure frequency during the maintenance dosing in Period 2 (Weeks 13 to 16) and Period 4 (Weeks 27-30).Time frame: 30 weeks
Locations
27 sites in 8 countries. Site status is shown where the registry gives one.
David Geffen School of Medicine at UCLA (Site #: 101)
Los Angeles, California
Kennedy Krieger Institute (Site #: 110)
Baltimore, Maryland
Boston Children's Hospital (Site #: 102)
Boston, Massachusetts
William Beaumont Hospital - Royal Oak (Site #: 104)
Royal Oak, Michigan
Minnesota Epilepsy Group PA (Site #: 105)
Roseville, Minnesota
Boston Children's Health Physicians (BCHP) (Site #: 111)
Hawthorne, New York
Duke Children's Hospital and Health Center (Site #: 106)
Durham, North Carolina
University Hospitals Cleveland Medical Center, Rainbow Babies and Childrens Hospital (Site #: 107)
Cleveland, Ohio
The University of Texas Medical School at Houston (Site #: 103)
Houston, Texas
Citi Neuro Centre (Site # 806)
Hyderabad, Andhra Pradesh, India
Rainbow Childrens Hospital (Site # 803)
Hyderabad, Andhra Pradesh, India
Jaslok Hospital and Research Centre (Site # 801)
Mumbai, Maharashtra, India
Deenanath Mangeshkar Hospital and Research Centre (Site # 805)
Pune, Maharashtra, India
All India Institute of Medical Sciences (Site # 804)
New Delhi, National Capital Territory of Delhi, India
Christian Medical College (Site # 807)
Vellore, Tamil Nadu, India
Hadassah Medical Center - PPDS (Site #: 503)
Jerusalem, Israel
ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda (Site # 183)
Milan, Lombardy, Italy
Instytut Pomnik Centrum Zdrowia Dziecka (Site # 262)
Warsaw, Masovian Voivodeship, Poland
Hospital Regional Universitario de Malaga - Hospital General (Site # 193)
Málaga, Spain
Centro de Neurología Avanzada (Site # 191)
Seville, Spain
Hospital Universitario Germans Trias i Pujol (Site # 194)
Badalona, Barcelona, Spain
Hospital Sant Joan de Deu - PIN (Site # 192)
Esplugues de Llobregat, Barcelona, Spain
Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi (Site #: 905)
Fatih, Istanbul, Turkey (Türkiye)
Yeditepe University Kosuyolu Hospital (Site #: 904)
Kadıköy, Istanbul, Turkey (Türkiye)
Istanbul Egitim ve Arastirma Hastanesi (Site #: 901)
Sultangazi, Istanbul, Turkey (Türkiye)
Salford Royal Hospital - PPDS (Site # 304)
Salford, Lancashire, United Kingdom
Noahs Ark Children's Hospital (Site # 306)
Cardiff, South Glamorgan, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.